Skip to content

Combination of Bone Marrow Concentrate and Iliac Cancellous Bone Graft in Alveolar Cleft Grafting

Combination of Bone Marrow Concentrate and Iliac Cancellous Bone Graft in Alveolar Cleft Grafting: a Clinical & Radiographic Evaluation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04414423
Enrollment
18
Registered
2020-06-04
Start date
2020-11-01
Completion date
2021-12-01
Last updated
2021-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alveolar Cleft Grafting

Keywords

bone marrow concentrate, alveolar cleft, CBCT, Bone density, bone volume

Brief summary

The aim of this study will be to analyze the newly formed bone volume and density, 6 months after alveolar cleft grafting using iliac cancellous bone graft, with and without bone marrow concentrate.

Detailed description

Twelve patients with unilateral alveolar cleft will be enrolled in this randomized comparative study. The patients will be divided into two groups, the control (group A) who received illiac cancellous bone graft and study group who received a combination of bone marrow concentrate and illiac cancellous bone graft (group B). Cone Beam CT (CBCT) images will be done prior to surgery to asses preoperative alveolar defect volume. Six months postoperative CBCT images will be done and postoperative newly bone formed volume and density will be evaluated and bone formation ratio (BF%) will be calculated as follows: BF% = (formed volume/alveolar defect) × 100%.

Interventions

PROCEDUREbone marrow concentrate alveolar cleft grafting

patients will undergo surgery to repair alveolar cleft with autogenous bone graft combined with bone marrow concentrate

PROCEDUREAutogenous alveolar grafting

patients will undergo surgery to repair alveolar cleft with autogenous bone graft

Sponsors

Fayoum University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Eighteen patients will be divided into two equal groups. Each group comprises nine patients.

Eligibility

Sex/Gender
ALL
Age
8 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* Patients suffering from maxillary alveolar cleft * Patient with Primary, complete cleft lip

Exclusion criteria

* Syndromic cases will be excluded * Previous operated cases

Design outcomes

Primary

MeasureTime frameDescription
bone volumesix months postoperativeV= (A1xT) + ( A2 xT) + …….+ (An xT) where: V= volume A= area T= thickness of the axial C.T slice N=number of slices

Secondary

MeasureTime frameDescription
bone densitysix months postoperativethe average bone density will be measured from the CBCT
bone formation ratiosix months postoperativeBF% = (formed volume/alveolar defect) × 100%.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026